LOXL4 and head and neck squamous cell carcinoma: A recent paper by Gorogh, et al.20remarkably demonstrated that anti-LOXL4 monoclonal antibodies significantly inhibit growth in 80% of 15 HNSCC cell lines and cause extensive tumor destruction in 41 animals xenografted with HNSCC.